脑部放疗，上午比下午敏感许多！2 ^ Y8 ?/ |9 X X. G+ a
8 t' o1 |3 D3 J! ?, K7 y
9 A: u, P1 Z+ b1 n1 GCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
' |8 ?5 r1 U6 @8 ?4 p" \" TGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
, h4 v n( S; ~/ [Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
: q; \) F% X$ Q, v0 j) ]SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.6 q/ R7 g9 Q/ t$ F
! V, d2 h6 s- ` }. |6 f8 a- n
Abstract
! q C* Q. z! SBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.3 ]3 R, Z/ \8 C% n: _1 M
( O% W9 N9 X0 M* T4 MMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic./ _2 \6 O7 f% g/ ] r& ]8 _% V
, N! G v/ J# F, ^/ U. {& [
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
# z3 D6 Z4 y& q. t! Y, O: y' {' t( ]5 X5 V3 X9 X7 f
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
! n3 \# h' e5 B4 h2 u$ c3 ^1 I$ n5 E# ?7 ?6 q p/ @4 U7 U
|
4 S( K0 E+ }' m
显身卡
